Hyaluronic acid products each carry a distinct J-code: J7321 for Hyalgan, J7322 for Synvisc or Synvisc-One, J7323 for Euflexxa, and J7325 for Orthovisc, all billed per dose
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
An alarming or concerning B12 level is below 200 picograms per milliliter (pg/mL)
Because most of the cost is incurred at inception of therapy, the best way to achieve cost savings is by increasing the longevity of the system to average the high initial costs over a long pump life span
This was an easy and quick process to order the product
Patients with even mid-range to high-range levels of vitamin B12 often still have a high MCV and high homocysteine (discussed below) and can benefit from vitamin B12 levels
